Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models-Reference-Cited by-同舟云学术

Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models

Published:2017-09-11 Issue:10 Volume:8 Page:1031-1036
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Tavares Maurício T.¹^ORCID,Shen Sida¹,Knox Tessa²,Hadley Melissa²,Kutil Zsófia³,Bařinka Cyril³,Villagra Alejandro²,Kozikowski Alan P.⁴^ORCID

Affiliation:

1. Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States

2. Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC 20052, United States

3. Institute of Biotechnology, BIOCEV, Prumyslova 595, 252 50 Vestec, Czech Republic

4. StarWise Therapeutics LLC, University Research Park, Inc., 510 Charmany Drive, Madison, Wisconsin 53719, United States

Funder

National Cancer Institute

National Institute of Neurological Disorders and Stroke

Melanoma Research Foundation

European Regional Development Fund

Grantov? Agentura Cesk? Republiky

Akademie Ved Cesk? Republiky

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.7b00223

Reference34 articles.

1. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma

2. https://www.cancer.gov/about-cancer/treatment/drugs/fda-dabrafenib(accessed July 2017) andhttps://www.cancer.gov/about-cancer/treatment/drugs/fda-trametinib(accessed July 2017) .

3. Immune Checkpoint Blockade in Cancer Therapy

4. Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma;Journal of Personalized Medicine;2024-06-30

2. Targeting HDAC6 improves anti-CD47 immunotherapy;Journal of Experimental & Clinical Cancer Research;2024-02-27

3. Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence;Frontiers in Pharmacology;2023-11-15

4. HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation;Frontiers in Immunology;2023-07-21

5. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12